Clinical Trial Update: T-DXd Therapy for HER2-low Breast Cancer Patients With Brain Metastases [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for trastuzumab deruxtecan (Enhertu) in HER2-low breast cancer patients with brain metastases, currently active but not recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Breast Cancer

Drugs mentioned

• Enhertu (trastuzumab deruxtecan)

Snippet

Sponsor: MedSIR | Conditions: Breast Cancer, Metastatic Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING